Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review
Open Access
- 22 December 2017
- journal article
- review article
- Published by Informa UK Limited in Journal of Chemotherapy
- Vol. 29 (sup1), 2-9
- https://doi.org/10.1080/1120009x.2017.1380395
Abstract
Urinary tract infections (UTIs) are among the most frequent infectious diseases affecting humans, and represent an important public health problem with a substantial economic burden. Due to the high empiric use of antibiotics for the treatment of UTI, antibacterial resistance of Enterobacteriaceae, specifically the main uropathogens Escherichia coli and Klebsiella pneumoniae, has significantly increased worldwide. In this article the worldwide epidemiology of resistant Gram-negative bacteria causing UTIs, with a special focus on extended spectrum beta lactamase (ESBL) positive pathogens, as well as new threats such as multi-drug-resistant (MDR) clones (e.g. E. coli 131 (ST131) and K. pneumoniae ST258), are reviewed. The increased prevalence of MDR Enterobacteriaceae, limiting available treatment options for infections caused by these organisms, and the lack of new antibiotics provide good rationale for using older antibiotics, such as fosfomycin, that have been shown to retain some activity against MDR bacteria.Keywords
This publication has 54 references indexed in Scilit:
- Multiresistant Uropathogenic Escherichia coli from a Region in India Where Urinary Tract Infections Are Endemic: Genotypic and Phenotypic Characteristics of Sequence Type 131 Isolates of the CTX-M-15 Extended-Spectrum-β-Lactamase-Producing LineageAntimicrobial Agents and Chemotherapy, 2012
- Genetic support and diversity of acquired extended-spectrum β-lactamases in Gram-negative rodsInfection, Genetics and Evolution, 2012
- Susceptibility of Klebsiella pneumoniae Isolates from Intra-Abdominal Infections and Molecular Characterization of Ertapenem-Resistant IsolatesAntimicrobial Agents and Chemotherapy, 2011
- Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapyInfection, 2011
- Increasing prevalence and dissemination of NDM-1 metallo- -lactamase in India: data from the SMART study (2009)Journal of Antimicrobial Chemotherapy, 2011
- Oral Treatment Options for Ambulatory Patients with Urinary Tract Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coliAntimicrobial Agents and Chemotherapy, 2010
- Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year intervalJournal of Antimicrobial Chemotherapy, 2010
- Hospital-Acquired Infections Due to Gram-Negative BacteriaNew England Journal of Medicine, 2010
- The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroupJournal of Antimicrobial Chemotherapy, 2008
- CTX-M-Type Extended-Spectrum β-Lactamases in Italy: Molecular Epidemiology of an Emerging Countrywide ProblemAntimicrobial Agents and Chemotherapy, 2006